Chemours (CC) Competitors $19.25 +0.40 (+2.12%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CC vs. AXTA, CSWI, ESI, ICL, ALTM, MEOH, PCT, PRM, TROX, and NGVTShould you be buying Chemours stock or one of its competitors? The main competitors of Chemours include Axalta Coating Systems (AXTA), CSW Industrials (CSWI), Element Solutions (ESI), ICL Group (ICL), Arcadium Lithium (ALTM), Methanex (MEOH), PureCycle Technologies (PCT), Perimeter Solutions (PRM), Tronox (TROX), and Ingevity (NGVT). These companies are all part of the "chemicals" industry. Chemours vs. Axalta Coating Systems CSW Industrials Element Solutions ICL Group Arcadium Lithium Methanex PureCycle Technologies Perimeter Solutions Tronox Ingevity Axalta Coating Systems (NYSE:AXTA) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Does the MarketBeat Community believe in AXTA or CC? Chemours received 110 more outperform votes than Axalta Coating Systems when rated by MarketBeat users. However, 63.58% of users gave Axalta Coating Systems an outperform vote while only 60.83% of users gave Chemours an outperform vote. CompanyUnderperformOutperformAxalta Coating SystemsOutperform Votes52263.58% Underperform Votes29936.42% ChemoursOutperform Votes63260.83% Underperform Votes40739.17% Which has more volatility and risk, AXTA or CC? Axalta Coating Systems has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Which has preferable earnings & valuation, AXTA or CC? Axalta Coating Systems has higher earnings, but lower revenue than Chemours. Axalta Coating Systems is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxalta Coating Systems$5.18B1.64$267.40M$1.4826.28Chemours$6.03B0.48-$238M$0.5038.50 Do analysts recommend AXTA or CC? Axalta Coating Systems presently has a consensus target price of $42.45, suggesting a potential upside of 9.14%. Chemours has a consensus target price of $24.88, suggesting a potential upside of 29.22%. Given Chemours' higher probable upside, analysts plainly believe Chemours is more favorable than Axalta Coating Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Axalta Coating Systems 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00Chemours 0 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.38 Do insiders & institutionals have more ownership in AXTA or CC? 98.3% of Axalta Coating Systems shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.4% of Axalta Coating Systems shares are owned by insiders. Comparatively, 0.5% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is AXTA or CC more profitable? Axalta Coating Systems has a net margin of 6.22% compared to Chemours' net margin of 1.34%. Chemours' return on equity of 29.48% beat Axalta Coating Systems' return on equity.Company Net Margins Return on Equity Return on Assets Axalta Coating Systems6.22% 24.92% 6.25% Chemours 1.34%29.48%2.74% Does the media refer more to AXTA or CC? In the previous week, Axalta Coating Systems had 11 more articles in the media than Chemours. MarketBeat recorded 15 mentions for Axalta Coating Systems and 4 mentions for Chemours. Chemours' average media sentiment score of 0.93 beat Axalta Coating Systems' score of 0.91 indicating that Chemours is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Axalta Coating Systems 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAxalta Coating Systems beats Chemours on 11 of the 19 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Chemours News Delivered to You Automatically Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CC vs. The Competition Export to ExcelMetricChemoursChemicals & allied products IndustryMaterials SectorNYSE ExchangeMarket Cap$2.88B$3.85B$2.84B$19.89BDividend Yield5.29%2.86%5.25%3.54%P/E Ratio38.5020.08117.1942.83Price / Sales0.4836.46586,861.5318.13Price / Cash3.7810.8623.4517.86Price / Book3.872.843.475.52Net Income-$238M$244.18M$150.91M$986.45M7 Day Performance0.47%-1.96%0.45%-0.22%1 Month Performance-2.04%-4.89%-5.56%0.12%1 Year Performance-28.78%12.68%27.68%23.71% Chemours Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCChemours4.71 of 5 stars$19.25+2.1%$24.88+29.2%-28.8%$2.82B$6.03B38.506,200AXTAAxalta Coating Systems4.4866 of 5 stars$38.90+0.2%$42.45+9.1%+25.5%$8.47B$5.18B26.2812,000CSWICSW Industrials4.3895 of 5 stars$412.03-1.1%N/A+143.7%$7.00B$792.84M55.982,600ESIElement Solutions4.3159 of 5 stars$27.71flat$31.00+11.9%+34.5%$6.71B$2.33B24.965,300Dividend AnnouncementPositive NewsICLICL Group1.9496 of 5 stars$4.44+1.1%$4.00-9.8%-15.1%$5.83B$6.93B14.3113,350News CoverageALTMArcadium Lithium2.9942 of 5 stars$5.19flat$11.00+111.9%N/A$5.58B$1.21B19.221,470MEOHMethanex4.806 of 5 stars$44.42-0.1%$55.88+25.8%-0.4%$3.00B$3.72B20.761,451Dividend AnnouncementAnalyst ForecastPCTPureCycle Technologies1.3268 of 5 stars$11.99+2.7%$10.60-11.6%+184.8%$2.02BN/A0.00146Analyst ForecastGap UpPRMPerimeter Solutions1.1559 of 5 stars$13.42+1.1%$14.50+8.0%+226.5%$1.94B$322.11M0.00240TROXTronox4.268 of 5 stars$11.68+0.9%$18.00+54.1%-8.1%$1.83B$2.85B0.006,500Positive NewsNGVTIngevity2.5698 of 5 stars$46.22+0.5%$52.17+12.9%+15.0%$1.67B$1.69B0.001,700Positive News Related Companies and Tools Related Companies AXTA Alternatives CSWI Alternatives ESI Alternatives ICL Alternatives ALTM Alternatives MEOH Alternatives PCT Alternatives PRM Alternatives TROX Alternatives NGVT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemours With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
